These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8191891)

  • 61. The effect of extracellular Ca2+ and related ions on the cardiac action of milrinone.
    Farah AE; Canniff PC; Bentley RG; Frangakis CJ
    J Cardiovasc Pharmacol; 1988 May; 11(5):591-600. PubMed ID: 2455846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Electropharmacological effects of UK-1745, a novel cardiotonic drug, in guinea-pig ventricular myocytes.
    Uemura H; Sakamoto N; Nakaya H
    Eur J Pharmacol; 1999 Nov; 383(3):361-71. PubMed ID: 10594330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of milrinone and atrial pacing on stunned myocardium.
    Schad H; Heimisch W; Eising GP; Mendler N
    Eur J Cardiothorac Surg; 1997 Jun; 11(6):1125-32. PubMed ID: 9237598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
    Yano M; Kohno M; Ohkusa T; Mochizuki M; Yamada J; Kohno M; Hisaoka T; Ono K; Tanigawa T; Kobayashi S; Matsuzaki M
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1898-905. PubMed ID: 11009478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum.
    Levijoki J; Pollesello P; Grossini E; Papp Z
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):827-832. PubMed ID: 35170487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of diethyl-stilboestrol on contractile response and action potential of rabbit papillary muscle.
    Khan AR; Wohlfart B
    Acta Physiol Scand; 1981 Feb; 111(2):201-4. PubMed ID: 7282396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure-activity relationships of milrinone analogues determined in vitro in a rabbit heart membrane Ca(2+)-ATPase model.
    Cody V; Wojtczak A; Davis FB; Davis PJ; Blas SD
    J Med Chem; 1995 May; 38(11):1990-7. PubMed ID: 7783130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone.
    Fossa P; Menozzi G; Dorigo P; Floreani M; Mosti L
    Bioorg Med Chem; 2003 Nov; 11(22):4749-59. PubMed ID: 14556790
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potentiation of the contraction following a prolonged depolarization in isolated ferret myocardium.
    Arlock P; Wohlfart B; Noble M
    Acta Physiol Scand; 1998 May; 163(1):3-11. PubMed ID: 9648617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ischemia-dependent efficacy of phosphodiesterase inhibition.
    Caldarone CA; Krukenkamp IB; Burns PG; Misare BD; Gaudette GR; Levitsky S
    Ann Thorac Surg; 1994 Mar; 57(3):540-5. PubMed ID: 8147619
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.
    Rendig SV; Amsterdam EA
    Cardiology; 1994; 84(2):99-105. PubMed ID: 8174147
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.
    Zhang YI; Ritchie RH; Horowitz JD
    Br J Clin Pharmacol; 1995 Jul; 40(1):25-30. PubMed ID: 8527264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat.
    Lindgren S; Andersson KE
    Acta Physiol Scand; 1991 May; 142(1):77-82. PubMed ID: 1652182
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myocardial force interval relationships: influence of external sodium and calcium, muscle length, muscle diameter and stimulation frequency.
    Mörner SE; Wohlfart B
    Acta Physiol Scand; 1992 Aug; 145(4):323-32. PubMed ID: 1382357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of a new inotropic drug (DN-9693) on Ca2+ transients and contraction in ferret ventricular muscles.
    Tanaka T; Kawai M; Kurihara S
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):227-32. PubMed ID: 7475047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells.
    Olson EM; Kim D; Smith TW; Marsh JD
    J Mol Cell Cardiol; 1987 Jan; 19(1):95-104. PubMed ID: 2435920
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of cyclic AMP and the dihydropyridine-sensitive channels on the mechanism of action of milrinone (Corotrope).
    Frangakis CJ; Lanni C; Lasher KP; Bentley RG; Farah AE
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):915-24. PubMed ID: 2484087
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Milrinone inhibits contractility in skinned skeletal muscle fibers.
    Seow CY; Morishita L; Bressler BH
    Am J Physiol; 1998 May; 274(5):C1306-11. PubMed ID: 9612218
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Age-dependent reduction of the response of rat cardiac muscle to the phosphodiesterase inhibitor milrinone.
    Canepari M; Polla B; Gualea MR; Zanardi C; Reggiani C
    Arch Int Physiol Biochim Biophys; 1994; 102(5):265-9. PubMed ID: 7849274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pharmacologic action profile of crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart].
    Joseph G; Zhao Y; Klaus W
    Arzneimittelforschung; 1995 Dec; 45(12):1261-5. PubMed ID: 8595081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.